BR112017028456A2 - composto, e, método de prevenção e/ou tratamento de hiv - Google Patents

composto, e, método de prevenção e/ou tratamento de hiv

Info

Publication number
BR112017028456A2
BR112017028456A2 BR112017028456A BR112017028456A BR112017028456A2 BR 112017028456 A2 BR112017028456 A2 BR 112017028456A2 BR 112017028456 A BR112017028456 A BR 112017028456A BR 112017028456 A BR112017028456 A BR 112017028456A BR 112017028456 A2 BR112017028456 A2 BR 112017028456A2
Authority
BR
Brazil
Prior art keywords
prevention
hiv
treatment
compound
methods
Prior art date
Application number
BR112017028456A
Other languages
English (en)
Portuguese (pt)
Inventor
De La Rosa Martha
Samano Vincente
Mieczyslaw Kazmierski Wieslaw
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of BR112017028456A2 publication Critical patent/BR112017028456A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112017028456A 2015-07-02 2016-06-30 composto, e, método de prevenção e/ou tratamento de hiv BR112017028456A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562187937P 2015-07-02 2015-07-02
PCT/IB2016/053947 WO2017002078A1 (en) 2015-07-02 2016-06-30 Inhibitors of indoleamine 2,3-dioxygenase

Publications (1)

Publication Number Publication Date
BR112017028456A2 true BR112017028456A2 (pt) 2018-08-28

Family

ID=56363880

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017028456A BR112017028456A2 (pt) 2015-07-02 2016-06-30 composto, e, método de prevenção e/ou tratamento de hiv

Country Status (11)

Country Link
US (1) US10239894B2 (https=)
EP (1) EP3317287B1 (https=)
JP (1) JP6654208B2 (https=)
KR (1) KR20180022988A (https=)
CN (1) CN107709338A (https=)
AU (1) AU2016285483B2 (https=)
BR (1) BR112017028456A2 (https=)
CA (1) CA2990335A1 (https=)
ES (1) ES2752455T3 (https=)
RU (1) RU2018101431A (https=)
WO (1) WO2017002078A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108530444B (zh) * 2018-06-11 2021-08-24 药康众拓(江苏)医药科技有限公司 一种新型nampt和ido双重抑制剂及其制备方法和医药用途
WO2020092528A1 (en) 2018-10-31 2020-05-07 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
US11203591B2 (en) 2018-10-31 2021-12-21 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds
EP3972695A1 (en) 2019-05-23 2022-03-30 Gilead Sciences, Inc. Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
CN110156629A (zh) * 2019-05-30 2019-08-23 广州药本君安医药科技股份有限公司 丙卡巴肼的合成方法
EP4052705A1 (en) 2021-03-05 2022-09-07 Universität Basel Vizerektorat Forschung Compositions for the treatment of ebv associated diseases or conditions
MX2023010371A (es) 2021-03-05 2024-02-12 Univ Basel Composiciones para el tratamiento de enfermedades o condiciones asociadas al veb.
WO2025119216A1 (zh) * 2023-12-04 2025-06-12 珠海联邦制药股份有限公司 硼酸类β-内酰胺酶抑制剂及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB427857A (en) 1934-08-02 1935-05-01 Newsum Sons & Company Ltd H A new or improved system of construction for skeleton structures, particularly vehicle body frames and door frames
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
EP1378509A4 (en) 2001-03-19 2009-03-25 Ono Pharmaceutical Co DRUGS WITH TRIAZASPIRO ç5.5] UNDECANDERIVATES AS ACTIVE SUBSTANCE
PL1879573T3 (pl) * 2005-05-10 2013-05-31 Incyte Holdings Corp Modulatory 2,3-dioksygenazy indoloaminy i sposoby ich zastosowania
UA91560C2 (ru) 2005-08-31 2010-08-10 Селджин Корпорэйшн Соединения ряда изоиндолимидов, их композиция и применение
JP5465720B2 (ja) * 2008-07-08 2014-04-09 インサイト・コーポレイション インドールアミン２，３−ジオキシゲナーゼの阻害剤としての１，２，５−オキサジアゾール
AU2011329485A1 (en) * 2010-11-18 2013-04-18 Glaxo Group Limited Compounds
CA2889182A1 (en) 2012-10-26 2014-05-01 The University Of Chicago Synergistic combination of immunologic inhibitors for the treatment of cancer

Also Published As

Publication number Publication date
AU2016285483B2 (en) 2018-07-19
CN107709338A (zh) 2018-02-16
RU2018101431A (ru) 2019-08-05
WO2017002078A1 (en) 2017-01-05
KR20180022988A (ko) 2018-03-06
ES2752455T3 (es) 2020-04-06
JP6654208B2 (ja) 2020-02-26
JP2018521056A (ja) 2018-08-02
US10239894B2 (en) 2019-03-26
EP3317287A1 (en) 2018-05-09
AU2016285483A1 (en) 2018-01-04
EP3317287B1 (en) 2019-07-31
US20180298035A1 (en) 2018-10-18
CA2990335A1 (en) 2017-01-05

Similar Documents

Publication Publication Date Title
BR112018005904A2 (pt) composto, e, método de prevenção e/ou tratamento do hiv.
BR112018005870A2 (pt) composto, e, método de prevenção e/ou tratamento do hiv.
BR112017028456A2 (pt) composto, e, método de prevenção e/ou tratamento de hiv
CO2020004301A2 (es) Derivados de 1-benzil-2-imino-4-fenil-5-oxoimidazolidina como inhibidores de la proteasa del vih
DOP2019000201A (es) Compuestos inhibidores del vih
BR112017022544A2 (pt) ?composto, composição, e, método para tratamento de infecção por hiv?.
JOP20170045B1 (ar) مركبات بيريدون رباعية الحلقة كمضادات فيروسية
GT201700234A (es) Derivados de indol mono o disustituidos como inhibidores de la replicación viral del dengue
BR112018077015A2 (pt) derivados de ácido borônico e usos terapêuticos dos mesmos
BR112018071216A2 (pt) inibidores de bromodomínios
EA201790389A1 (ru) Пирролопиримидиновые соединения, используемые в качестве агониста tlr7
TR201909152T4 (tr) Polisiklik-karbamoilpiridon bileşikleri ve bunların farmasötik kullanımı.
TR201905009T4 (tr) Polisiklik-karbamoilpiridon bileşikleri ve bunların farmasötik kullanımları.
BR112017000528A2 (pt) moduladores dos receptores toll-like para o tratamento do hiv
BR112018002689A2 (pt) composto, composição útil e método para tratamento de infecção por hiv
EA201590674A1 (ru) Производные 5-фенокси-3h-пиримидин-4-она и их применение в качестве ингибиторов обратной транскрипазы вич
MX376833B (es) Oxiesteroles y metodos de uso de los mismos.
EA201891063A1 (ru) Производные дигидроимидазопиразинона, применимые в лечении рака
BR112018013251A2 (pt) compostos heterocílicos tricíclicos fundidos como inibidores da hiv integrase
MX2016001480A (es) Formulacion de inhibidores de syk.
MX2017010506A (es) Nuevo derivado de quinoleina para usarse en el tratamiento y prevencion de infecciones virales.
BR112017000246A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal
EA202090978A1 (ru) Новые макроциклические производные, способ их получения и содержащие их фармацевтические композиции
BR112017006085A2 (pt) compostos 1-alquil-6-oxo-1,6-di-hidropiridin-3-ila e uso como moduladores sgrm
BR112019000453A2 (pt) combinação de ceftibuteno e ácido clavulânico para uso no tratamento de infecções bacterianas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired